Senate LDA lobbying filing

Pfizer

A public disclosure record: who filed, what they reported, and the program connections found in the text.

Reported amounts Program mentions Activity text Lobbyists

Registrant: Federal Health Policy Strategies Year: 2024 Period: Second Quarter Type: Q2

Filed as: PFIZER — FEDERAL HEALTH POLICY STRATEGIES. Search lda.senate.gov for those strings; the names above are this site’s casing of them, nothing else.

View on lda.senate.gov ↗

Reported income

$60.0K

Reported expenses

not reported

Connections in the record

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital…

Lobbying activities1

Health IssuesHCR
Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency ActH.R. 8816, the American Medical Innovation and Investment Act

Lobbyists1

DAN ELLING

Source: U.S. Senate Lobbying Disclosure Act database. Underlined dollar figures cite the filing record on lda.senate.gov and open to that citation. Amounts shown as “not reported” are absent from the filing itself.